Contact
Please use this form to send email to PR contact of this press release:
InterveXion Therapeutics Awarded Federal Grant to Fund Phase 2 Study for Methamphetamine Overdose
TO:
Misty Stevens
InterveXion Therapeutics
+1 501-554-2377